8-K: Premier Inc. Reports Strong Q3 2025 Financial Results, Raises Guidance

Premier Inc. announced positive Q3 2025 financial results, driven by better-than-expected performance in Supply Chain Services, leading to increased adjusted EBITDA and EPS guidance while reaffirming revenue guidance.

Summary

• Premier, Inc. reported its fiscal year 2025 third-quarter financial results, with total net revenue of $261.4 million, a 9% decrease year-over-year.
• Net income from continuing operations was $27.6 million, or $0.32 per share, compared to a net loss of $48.9 million, or a loss of $0.36 per share, in the prior-year period.
• Adjusted EBITDA was $71.7 million, a 25% decrease year-over-year, but a 43% increase from the previous quarter.
• Adjusted EPS was $0.44, a 10% decrease year-over-year, but a 76% increase from the previous quarter.
• The company is increasing its adjusted EBITDA guidance to $247 million to $255 million and adjusted EPS guidance to $1.37 to $1.43 for fiscal year 2025.
• The midpoint of the consolidated revenue guidance range of $955 million to $995 million is reaffirmed.
• The company repurchased over 38 million shares of Class A common stock under its $1 billion authorization since February 2024.
• A quarterly cash dividend of $0.21 per share was declared, payable in June 2025.
• The company expects to transition or wind down the remaining Contigo Health assets by the end of the calendar year.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong Q3 results, increased guidance, and a focus on returning value to shareholders. While there are some challenges noted, the overall tone is optimistic and confident.

Positives

• Sequential growth in revenue, adjusted EBITDA, and adjusted EPS from Q2 to Q3.
• Supply Chain Services performed above expectations, driven by contract penetration and fee share arrangements.
• Rebound in Performance Services with higher enterprise license agreements and software licenses.
• Investments in advisory services are showing a healthy sales funnel and an uptick in new bookings.
• The company is ahead of schedule in completing contract negotiations with GPO members.
• The company is actively managing potential tariff impacts through member-led contracting strategies and supply chain resiliency efforts.
• The company is returning capital to stockholders through share repurchases and dividends.
• The company will no longer have the negative impact on free cash flow from the Tax Receivable Agreement starting on July 1, 2025.

Negatives

• Total net revenue decreased 9% year-over-year.
• Adjusted EBITDA decreased 25% year-over-year.
• Adjusted EPS decreased 10% year-over-year.
• Performance Services segment experienced lower consulting revenue compared to the prior-year period.
• Free cash flow decreased $13 million from the prior year period, mainly due to the timing of payments to OMNIA.

Risks

• Potential impact of tariffs on care delivery and healthcare system margins.
• Continued workforce shortages and reimbursement challenges faced by healthcare providers.
• Uncertainty regarding potential federal funding changes for healthcare systems.
• The company is still working to transition to partners or wind down the remaining Contigo Health assets by the end of the calendar year, which could present challenges.

Future Outlook

Premier is increasing its adjusted EBITDA guidance to $247 million to $255 million and adjusted EPS guidance to $1.37 to $1.43 for fiscal year 2025, while reaffirming the midpoint of its consolidated revenue guidance range of $955 million to $995 million.

Management Comments

• Michael J. Alkire, Premier's President and CEO, stated that the company's overall revenue and profitability for the third quarter experienced meaningful sequential growth and exceeded expectations, most notably in the supply chain services segment.
• Glenn Coleman, Premier's Chief Administrative and Financial Officer, noted that revenue, adjusted EBITDA, and adjusted EPS saw significant sequential growth from Q2 to Q3 in both business segments and exceeded expectations for the third quarter.

Industry Context

Premier's focus on technology-enabled performance improvement and supply chain excellence aligns with the healthcare industry's need to address rising costs, workforce shortages, and reimbursement challenges. The company's integrated digital supply chain solution and strategic partnerships, such as the one with Epic, position it to support providers in navigating the evolving healthcare landscape.

Comparison to Industry Standards

• It is difficult to compare Premier's results directly to industry standards without detailed competitor data.
• However, the company's focus on supply chain optimization, workforce planning, and clinical transformation aligns with the priorities of many healthcare providers.
• Premier's adjusted EBITDA margin of 28.4% in Q3 2025 is a key indicator of its profitability compared to peers.
• The company's share repurchase program and dividend payments demonstrate its commitment to returning value to stockholders, which is a common practice among publicly traded companies.

Stakeholder Impact

• Shareholders will benefit from increased adjusted EPS guidance, share repurchases, and dividend payments.
• Healthcare providers will benefit from Premier's supply chain solutions, performance improvement services, and technology offerings.
• Suppliers will benefit from Premier's member-led contracting process and efforts to manage tariff impacts.
• Employees will benefit from the company's continued investment in its people and core capabilities.

Next Steps

• Continue to execute the plan to reinvigorate Performance Services.
• Continue to monitor developments related to tariffs and support providers and suppliers with supply chain solutions.
• Continue to invest in people and core capabilities, including advisory services, technology, and supply chain solutions.
• Complete the final settlement of the 2025 ASR by the end of the first quarter of fiscal year 2026.
• Make the final payment associated with the termination of the Tax Receivable Agreement by the end of fiscal year 2025.

Key Dates

Keywords

financial results, supply chain services, performance services, adjusted EBITDA, adjusted EPS, net revenue, share repurchase, dividends, tariff, Contigo Health